Spectrawave, Inc.

Spectrawave, Inc. — FDA 510(k) Submissions

Spectrawave, Inc. has submitted 6 FDA 510(k) premarket notifications since 2023, of which 6 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include System, Imaging, Optical Coherence Tomography (oct), X-ray Angiographic Imaging Based Coronary Vascular Simulation Software Device . Use the specialty filter in the sidebar to narrow results.